Copyright and DMCA Policy

1. Scope

Bomi Health, Inc. (“Bomi,” “we,” “us,” or “our”) respects the intellectual-property rights of others. This Copyright and Digital Millennium Copyright Act (“DMCA”) Policy explains how to report material stored through Bomi’s services at a user’s direction that you believe infringes copyright, how a user may respond, and how Bomi addresses repeat infringement and other unlawful or prohibited content.

This Policy implements procedures under 17 U.S.C. § 512. Registration of a designated agent and publication of this Policy do not by themselves establish that Bomi qualifies for a statutory limitation of liability in every circumstance. Bomi will apply the requirements of applicable law to each matter.

2. Registered Designated Agent

Notices of claimed copyright infringement must be directed to Bomi’s registered designated agent:

Designated Agent: Copyright Manager
Service Provider: Bomi Health, Inc.
Address: 1710 Mullikin Dr, Champaign, IL 61822
Phone: (217) 819-8586
Email: dmca@billwithbomi.com
Copyright Office Registration: DMCA-1075422
Status: Active, effective July 10, 2026

This contact is only for copyright notices and counter-notices. Send privacy requests to privacy@billwithbomi.com and technical-support requests to support@billwithbomi.com. Bomi maintains the agent details above both here and in the United States Copyright Office directory. The sender should verify current details before submitting a notice.

3. Notice of Claimed Infringement

A copyright owner or person authorized to act for the owner may send the designated agent a written notice that substantially includes all of the following:

1. a physical or electronic signature of the copyright owner or person authorized to act for the owner;
2. identification of the copyrighted work claimed to have been infringed, or a representative list if one notice covers multiple works at a single online location;
3. identification of the material claimed to be infringing or the subject of infringing activity, and information reasonably sufficient for Bomi to locate it, such as the exact URL, account, file name, record location, or other specific identifier;
4. information reasonably sufficient for Bomi to contact the notifying party, including name, mailing address, telephone number, and email address;
5. a statement that the notifying party has a good-faith belief that use of the material in the complained-of manner is not authorized by the copyright owner, its agent, or law; and
6. a statement that the information in the notice is accurate and, under penalty of perjury, that the notifying party is authorized to act for the owner of an exclusive right allegedly infringed.

Send the notice by email or mail to the designated agent in Section 2. Do not include medical records, authentication links, full payment information, or other sensitive information unrelated to identifying the copyrighted work and material at issue. Bomi may contact a sender to obtain missing information when appropriate.

4. Bomi’s Response

When Bomi receives a notice that substantially complies with 17 U.S.C. § 512(c)(3), Bomi will act expeditiously as appropriate to remove or disable access to the material claimed to be infringing. Bomi will take reasonable steps to promptly notify the user that supplied the material and will provide information about the counter-notice process where applicable.

Bomi may send a copy of a notice, including the sender’s contact information, to the affected user, the user’s healthcare practice, Bomi’s advisers and service providers, a court or government agency, or another person as reasonably necessary to process the notice, comply with law, or protect legal rights. A notice may therefore become part of a legal record. Bomi does not adjudicate copyright ownership or whether a disputed use is a fair use.

5. Counter-Notice

A user who believes material was removed or disabled because of mistake or misidentification may send the designated agent a written counter-notice that substantially includes:

1. the user’s physical or electronic signature;
2. identification of the material removed or disabled and the location where it appeared before removal or disabling;
3. a statement under penalty of perjury that the user has a good-faith belief the material was removed or disabled because of mistake or misidentification;
4. the user’s name, address, and telephone number; and
5. a statement that the user consents to the jurisdiction of the Federal District Court for the judicial district where the user’s address is located—or, if the address is outside the United States, for any judicial district where Bomi may be found—and will accept service of process from the person who submitted the original notice or that person’s agent.

Send the counter-notice to the designated agent in Section 2. Bomi will promptly provide a qualifying counter-notice to the person who sent the original notice. Subject to 17 U.S.C. § 512(g), Bomi will restore the material between ten and fourteen business days after receiving the counter-notice unless the designated agent first receives notice that the complaining party filed a court action seeking to restrain the user from infringing activity involving the material.

6. Repeat Infringers and Standard Technical Measures

Bomi has adopted and reasonably implements a policy providing for termination, in appropriate circumstances, of users and account holders who are repeat infringers. Depending on the circumstances, Bomi may warn a user; remove or disable access to material; restrict upload, sharing, or other content functions; suspend access; or terminate an account or service relationship. Bomi may consider qualifying notices, counter-notices, retractions, court decisions, admissions, the frequency and nature of conduct, and other reliable evidence. Bomi will not treat an unresolved allegation as a final judicial determination of infringement.

Termination of access does not require Bomi to destroy a healthcare practice’s records when law, professional duties, a legal hold, or the governing customer agreement requires continued retention or protection. Bomi may preserve records while preventing the terminated user from accessing or distributing material. Bomi accommodates and does not interfere with standard technical measures that meet 17 U.S.C. § 512(i), to the extent applicable.

7. Other Content Removal and Restrictions

Separate from the DMCA process, Bomi may investigate, quarantine, remove, disable, preserve, or restrict access to content when Bomi reasonably believes the action is necessary to enforce applicable terms, follow a customer’s lawful instruction, protect privacy or security, prevent fraud or harm, comply with law or legal process, or address content that is unlawful, infringing, malicious, or submitted without authority. Bomi has no general obligation to monitor user content.

Bomi will limit an action to affected material, users, or functions to the extent reasonably practicable; preserve original records when applicable law or the governing customer agreement requires it; and provide notice and an opportunity to respond where reasonably practicable and lawful. These provisions do not reduce Bomi’s duties under a Business Associate Agreement or applicable health-record and patient-access law.

8. Misrepresentations

Under 17 U.S.C. § 512(f), a person who knowingly materially misrepresents that material or activity is infringing, or that material was removed or disabled by mistake or misidentification, may be liable for damages, costs, and attorneys’ fees. Consider obtaining legal advice before submitting a notice or counter-notice.

9. Changes and Questions

Bomi may update this Policy to reflect changes in law, registration information, procedures, or the services. The effective date above identifies the current version. Copyright notices and counter-notices must go to the designated agent in Section 2. General questions about this Policy may be sent to dmca@billwithbomi.com.